Stock 0R1F BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Quotes Bristol-Myers Squibb Company London S.E.

Equities

0R1F

US1101221083

Pharmaceuticals

Market Closed - London S.E.
Other stock markets
 16:30:00 21/06/2024 BST 		5-day change 1st Jan Change
41.04 USD +0.84% Intraday chart for Bristol-Myers Squibb Company -1.11% -19.75%
06-22 Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI®? in Combination with Cetuximab for Adult Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer CI
06-21 Bristol-Myers Squibb's Colorectal Cancer Therapy Receives FDA Approval MT

Quotes 5-day view

Delayed Quote London S.E.
Bristol-Myers Squibb Company(0R1F) : Historical Chart (5-day)
  18/06/2024 19/06/2024 20/06/2024 21/06/2024
Last 40.8895 $ 40.845 $ 40.8405 $ 41.5597 $
Volume 281 577 0 10 629 42 142
Change +0.11% -0.11% -0.01% +1.76%
Opening 40.90 40.85 40.71 41.05
High 41.21 40.85 40.92 41.85
Low 40.10 40.85 39.97 41.08

Performance

1 day+0.84%
1 week-1.11%
Current month-0.01%
1 month-3.51%
3 months-21.14%
6 months-19.64%
Current year-19.75%
1 year-37.15%
3 years-37.59%
5 years-16.06%

Volumes

markets
Daily volume
513
Estimated daily volume
513
Avg. Volume 20 sessions
66 872
Daily volume ratio
0.01
Avg. Volume 20 sessions USD
2 744 761.24
Record volume 1
6 547 076
Record volume 2
4 413 185
Record volume 3
4 408 551
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
84 996 307 025
Net sales (USD)
45 006 000 000
Number of employees
34 100
Sales / Employee (USD)
1 319 824
Free-Float
69.27 %
Free-Float capitalization (USD)
84 904 836 562
Average Daily Capital Traded
0%

Highs and lows

1 week
39.97
Extreme 39.97
41.85
1 month
39.92
Extreme 39.92
43.11
Current year
39.92
Extreme 39.92
55.00
1 year
39.92
Extreme 39.92
65.31
3 years
39.92
Extreme 39.92
81.40
5 years
39.92
Extreme 39.92
81.40
10 years
39.92
Extreme 39.92
81.40

Indicators

Moving average 5 days
40.94
Moving average 20 days
41.41
Moving average 50 days
44.20
Moving average 100 days
47.56
Price spread / (MMA5)
-0.27%
Price spread / (MMA20)
+0.89%
Price spread / (MMA50)
+7.68%
Price spread / (MMA100)
+15.88%
STIM
RSI 9 days
35.51
RSI 14 days
35.69

Sector Comparison - Other Pharmaceuticals

Name Change 5d. change 1st Jan change 1-year change Capi.
BRISTOL-MYERS SQUIBB COMPANY Stock Bristol-Myers Squibb Company
+0.84%-1.11%-19.75%-37.15% 85B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
-0.24%+0.62%+51.63%+93.12% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
-0.59%-0.31%+41.51%+81.93% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
+0.66%+2.21%-5.10%-10.19% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+0.81%+0.96%+19.90%+14.95% 331B
ABBVIE INC. Stock AbbVie Inc.
-1.01%+1.07%+9.95%+24.00% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+0.60%-0.30%+17.66%+7.52% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+1.12%+2.10%+3.39%-8.02% 228B
NOVARTIS AG Stock Novartis AG
-0.36%-1.07%+10.75%+4.36% 214B
AMGEN INC. Stock Amgen Inc.
-0.56%+3.19%+6.99%+34.18% 165B
PFIZER, INC. Stock Pfizer, Inc.
0.00%+0.76%-3.65%-28.38% 157B
SANOFI Stock Sanofi
-0.56%+1.38%-2.38%-10.24% 117B
GILEAD SCIENCES, INC. Stock Gilead Sciences, Inc.
+3.18%+8.62%-12.76%-9.53% 88.04B
GSK PLC Stock GSK plc
-1.17%-0.34%+10.26%+17.66% 82.33B
DAIICHI SANKYO CO., LTD. Stock Daiichi Sankyo Co., Ltd.
-0.26%+0.52%+40.75%+17.31% 65.3B
ALLERGAN PLC Stock Allergan plc
-.--%+1.73% - - 63.66B
Average+0.15%+1.41%+11.28%+12.77%
Weighted average by Cap.+0.01%+0.94%+21.58%+34.60%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Last transactions

9d2bfdeb8030.C-sfclTq3s0A-ZuLQ9ScdP5Kb-TQcFu-_gy7rXONxaE.bN5dJQ6b7IAxwdi8AuepE7YJC7WDNin4nXnW7D3n9vhmpXY4E6i3g2-q6A
DatePriceVolumeDaily volume
15:05:23 41.77 225 425

Chart Bristol-Myers Squibb Company

Chart Bristol-Myers Squibb Company
More charts

Monthly variations

Annual change

2024-18.74%
2023-28.22%
2022+13.95%
2021+2.08%
2020-3.59%
2019+27.54%
2018-13.95%
2014+3.45%
  1. Stock Market
  2. Equities
  3. BMY Stock
  4. 0R1F Stock
  5. Quotes Bristol-Myers Squibb Company